Breaking News
Sort by:
Top Post
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
IAVI, the nonprofit scientific research organization, and biotechnology company Moderna announced today that first doses […]
ViiV Healthcare Announces US FDA Approval of Apretude (Cabotegravir Extended-release Injectable Suspension), the First and Only Long-acting Injectable Option for HIV Prevention
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer […]
New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults
Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today […]
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has received funding […]
Bio-Rad Launches IgA and IgM SARS-CoV-2 Bio-Plex Pro Immunoassay Panels to Study COVID-19 Antibody Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious […]
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]
CUNY SPH and NYC Health Department Awarded $3.3 Million to Study New HIV Intervention
The National Institute of Mental Health (NIMH) has awarded the CUNY Graduate School of Public […]
X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer
X-Vax Technology, Inc. (X-VAX®), a biotechnology company developing vaccines based on a new approach that […]
Camber Pharma Launches Generic Kaletra
Camber Pharmaceuticals is pleased to announce that it has launched Lopinavir and RitonavirTablets, which is […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more